• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗结直肠癌患者中产肠毒素脆弱拟杆菌与细胞信号通路基因表达的相关性评估

Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer.

作者信息

Dadgar-Zankbar Leila, Shariati Aref, Bostanghadiri Narjess, Elahi Zahra, Mirkalantari Shiva, Razavi Shabnam, Kamali Fatemeh, Darban-Sarokhalil Davood

机构信息

Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Molecular and Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran.

出版信息

Infect Agent Cancer. 2023 Aug 29;18(1):48. doi: 10.1186/s13027-023-00523-w.

DOI:10.1186/s13027-023-00523-w
PMID:37644520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10463534/
Abstract

BACKGROUND

Colorectal cancer (CRC) is one of the most common cancers all over the world, and dysbiosis in the gut microbiota may play a role in colorectal carcinogenesis. Bacteroides fragilis can lead to tumorigenesis by changing signaling pathways, including the WNT/β-catenin pathway. Therefore, in the present study, we investigated the correlation between the enterotoxigenic B. fragilis amount and the expression of signaling pathway genes involved in CRC.

MATERIALS AND METHODS

B. fragilis was determined in 30 tumors and adjacent healthy tissues by the qPCR method. Next, the relationship between enterotoxigenic B. fragilis and the expression of signaling pathway genes, including CCND1, TP53, BCL2, BAX, WNT, TCF, AXIN, APC, and CTNNB1 was investigated. Additionally, possible correlations between clinicopathological features of the tumor samples and the abundance of B. fragilis were analyzed.

RESULTS

The results showed that B. fragilis was detected in 100% of tumor samples and 86% of healthy tissues. Additionally, enterotoxigenic B. fragilis colonized 47% of all samples, and bft-1 toxin was the most frequently found isotype among the samples. The analysis showed that the high level of B. fragilis has a significant relationship with the high expression of AXIN, CTNNB1, and BCL2 genes. On the other hand, our results did not show any possible correlation between this bacterium and the clinicopathological features of the tumor sample.

CONCLUSION

B. fragilis had a higher abundance in the tumor samples than in healthy tissues, and this bacterium may lead to CRC by making changes in cellular signaling pathways and genes. Therefore, to better understand the physiological effects of B. fragilis on the inflammatory response and CRC, future research should focus on dissecting the molecular mechanisms by which this bacterium regulates cellular signaling pathways.

摘要

背景

结直肠癌(CRC)是全球最常见的癌症之一,肠道微生物群失调可能在结直肠癌发生过程中起作用。脆弱拟杆菌可通过改变信号通路(包括WNT/β-连环蛋白通路)导致肿瘤发生。因此,在本研究中,我们调查了产肠毒素脆弱拟杆菌数量与结直肠癌中涉及的信号通路基因表达之间的相关性。

材料与方法

采用qPCR法测定30例肿瘤组织及相邻健康组织中的脆弱拟杆菌。接下来,研究产肠毒素脆弱拟杆菌与信号通路基因(包括CCND1、TP53、BCL2、BAX、WNT、TCF、AXIN、APC和CTNNB1)表达之间的关系。此外,分析了肿瘤样本的临床病理特征与脆弱拟杆菌丰度之间的可能相关性。

结果

结果显示,100%的肿瘤样本和86%的健康组织中检测到脆弱拟杆菌。此外,产肠毒素脆弱拟杆菌定殖于所有样本的47%,bft-1毒素是样本中最常见的亚型。分析表明,脆弱拟杆菌的高水平与AXIN、CTNNB1和BCL2基因的高表达有显著关系。另一方面,我们的结果未显示该细菌与肿瘤样本的临床病理特征之间有任何可能的相关性。

结论

脆弱拟杆菌在肿瘤样本中的丰度高于健康组织,这种细菌可能通过改变细胞信号通路和基因导致结直肠癌。因此,为了更好地理解脆弱拟杆菌对炎症反应和结直肠癌的生理影响,未来的研究应集中于剖析该细菌调节细胞信号通路的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff39/10463534/a74f1e2289f4/13027_2023_523_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff39/10463534/66c6ee010640/13027_2023_523_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff39/10463534/a74f1e2289f4/13027_2023_523_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff39/10463534/66c6ee010640/13027_2023_523_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff39/10463534/a74f1e2289f4/13027_2023_523_Fig2_HTML.jpg

相似文献

1
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer.伊朗结直肠癌患者中产肠毒素脆弱拟杆菌与细胞信号通路基因表达的相关性评估
Infect Agent Cancer. 2023 Aug 29;18(1):48. doi: 10.1186/s13027-023-00523-w.
2
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.伊朗患者中结直肠癌与具核梭杆菌和脆弱拟杆菌之间的关联:一项初步研究。
Infect Agent Cancer. 2021 Jun 9;16(1):41. doi: 10.1186/s13027-021-00381-4.
3
The association between fecal enterotoxigenic B. fragilis with colorectal cancer.脆弱拟杆菌肠毒素与结直肠癌的相关性。
BMC Cancer. 2019 Sep 5;19(1):879. doi: 10.1186/s12885-019-6115-1.
4
Comparison of microbiological profile of enterotoxigenic Bacteroides fragilis (ETBF) isolates from subjects with colorectal cancer (CRC) or intestinal pre-cancerous lesions versus healthy individuals and evaluation of environmental factors involved in intestinal dysbiosis.对比分析结直肠癌(CRC)或肠前病变患者与健康个体中产肠毒素脆弱拟杆菌(ETBF)分离株的微生物特征,并评估肠道菌群失调相关的环境因素。
Anaerobe. 2023 Aug;82:102757. doi: 10.1016/j.anaerobe.2023.102757. Epub 2023 Jun 26.
5
Screening for enterotoxigenic Bacteroides fragilis in stool samples.粪便样本中脆弱拟杆菌肠毒素的筛查。
Anaerobe. 2016 Aug;40:50-3. doi: 10.1016/j.anaerobe.2016.05.004. Epub 2016 May 7.
6
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.脆弱拟杆菌毒素基因在结直肠癌患者的结肠黏膜中普遍存在。
Clin Infect Dis. 2015 Jan 15;60(2):208-15. doi: 10.1093/cid/ciu787. Epub 2014 Oct 9.
7
Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer.结直肠癌患者中携带聚酮合酶基因(pks)的细菌和产肠毒素脆弱拟杆菌的患病率
Gut Pathog. 2022 Dec 28;14(1):51. doi: 10.1186/s13099-022-00523-y.
8
Toxigenic and non-toxigenic patterns I, II and III and biofilm-forming ability in strains isolated from patients diagnosed with colorectal cancer.从被诊断患有结直肠癌的患者中分离出的菌株的产毒和非产毒模式I、II和III以及生物膜形成能力。
Gut Pathog. 2020 Jun 5;12:28. doi: 10.1186/s13099-020-00366-5. eCollection 2020.
9
The Mechanism of Toxin Contributes to Colon Cancer Formation.毒素促成结肠癌形成的机制。
Malays J Med Sci. 2020 Jul;27(4):9-21. doi: 10.21315/mjms2020.27.4.2. Epub 2020 Aug 19.
10
Dietary Salt Administration Decreases Enterotoxigenic (ETBF)-Promoted Tumorigenesis via Inhibition of Colonic Inflammation.膳食盐摄入可通过抑制结肠炎症减少肠产毒性(ETBF)促进的肿瘤发生。
Int J Mol Sci. 2020 Oct 28;21(21):8034. doi: 10.3390/ijms21218034.

引用本文的文献

1
A landscape review with novel criteria to evaluate microbial drivers for cancer: priorities for innovative research targeting excessive cancer mortality in sub-Saharan Africa.一项采用新标准评估癌症微生物驱动因素的全景综述:针对撒哈拉以南非洲地区过高癌症死亡率的创新研究重点
Front Cell Infect Microbiol. 2025 Aug 20;15:1625818. doi: 10.3389/fcimb.2025.1625818. eCollection 2025.
2
Anaerobic gut bacteria and their potential role in the initiation, exacerbation, and development of human colorectal cancer: a narrative review.厌氧肠道细菌及其在人类结直肠癌的起始、恶化和发展中的潜在作用:一篇叙述性综述。
Front Cell Infect Microbiol. 2025 Jul 25;15:1559001. doi: 10.3389/fcimb.2025.1559001. eCollection 2025.
3

本文引用的文献

1
The combined effect of fish oil containing Omega-3 fatty acids and on colorectal cancer.含欧米伽-3脂肪酸的鱼油与……对结直肠癌的联合作用 (原文中“and”后面内容缺失)
Food Sci Nutr. 2022 Sep 28;10(12):4411-4418. doi: 10.1002/fsn3.3037. eCollection 2022 Dec.
2
A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer.肠毒素脆弱拟杆菌在结直肠癌中作用的系统评价。
Neoplasia. 2022 Jul;29:100797. doi: 10.1016/j.neo.2022.100797. Epub 2022 Apr 20.
3
Detection of and Four Other CRC-Associated Bacteria in Patient Stools Reveals a Potential "Driver" Role for Enterotoxigenic .
Gut Microbiota and Colorectal Cancer: A Balance Between Risk and Protection.
肠道微生物群与结直肠癌:风险与保护之间的平衡
Int J Mol Sci. 2025 Apr 15;26(8):3733. doi: 10.3390/ijms26083733.
4
Prevalence of enterotoxigenic in patients with colorectal cancer: a systematic review and meta-analysis.结直肠癌患者中产肠毒素菌的患病率:一项系统评价和荟萃分析。
Front Cell Infect Microbiol. 2025 Mar 7;15:1525609. doi: 10.3389/fcimb.2025.1525609. eCollection 2025.
5
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.结直肠癌患者中具核梭杆菌和脆弱拟杆菌的全球患病率:病例报告/病例系列概述及患病率研究的荟萃分析
BMC Gastroenterol. 2025 Feb 10;25(1):71. doi: 10.1186/s12876-025-03664-x.
6
Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery.结直肠癌患者与健康个体的微生物组差异:对疫苗抗原发现的启示
Immunotargets Ther. 2024 Dec 13;13:749-774. doi: 10.2147/ITT.S486731. eCollection 2024.
7
Goblet cells: guardians of gut immunity and their role in gastrointestinal diseases.杯状细胞:肠道免疫的守护者及其在胃肠道疾病中的作用
eGastroenterology. 2024 Oct;2(3). doi: 10.1136/egastro-2024-100098.
8
Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review.肠道微生物失调、饮食摄入和生活方式相关因素参与结直肠癌的表观遗传调控:叙事性综述。
Cancer Control. 2024 Jan-Dec;31:10732748241263650. doi: 10.1177/10732748241263650.
9
Unveiling the intratumoral microbiota within cancer landscapes.揭示癌症微环境中的肿瘤内微生物群。
iScience. 2024 May 3;27(6):109893. doi: 10.1016/j.isci.2024.109893. eCollection 2024 Jun 21.
10
Immune landscape in APC and TP53 related tumor microenvironment in colon adenocarcinoma: A bioinformatic analysis.结肠腺癌中APC和TP53相关肿瘤微环境的免疫景观:一项生物信息学分析。
Eur J Microbiol Immunol (Bp). 2024 Mar 12;14(2):154-165. doi: 10.1556/1886.2024.00015. Print 2024 May 14.
在患者粪便中检测到和其他四种 CRC 相关细菌,揭示了肠毒性 在其中的潜在“驱动”作用。
Front Cell Infect Microbiol. 2022 Mar 11;12:794391. doi: 10.3389/fcimb.2022.794391. eCollection 2022.
4
Tumorigenic bacteria in colorectal cancer: mechanisms and treatments.结直肠癌中的致瘤细菌:机制与治疗
Cancer Biol Med. 2021 Sep 30;19(2):147-62. doi: 10.20892/j.issn.2095-3941.2020.0651.
5
Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future.早期和晚期结直肠癌的肠道微生物群特征:未来的潜在诊断生物标志物。
Digestion. 2021;102(6):823-832. doi: 10.1159/000516689. Epub 2021 Aug 25.
6
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.伊朗患者中结直肠癌与具核梭杆菌和脆弱拟杆菌之间的关联:一项初步研究。
Infect Agent Cancer. 2021 Jun 9;16(1):41. doi: 10.1186/s13027-021-00381-4.
7
Fecal -- Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor.粪便——结直肠侧向发育型肿瘤无创诊断与预后的生物标志物。
Front Oncol. 2021 May 11;11:661048. doi: 10.3389/fonc.2021.661048. eCollection 2021.
8
Characterization of pathways involved in colorectal cancer using real-time RT-PCR gene expression data.利用实时逆转录聚合酶链反应基因表达数据对结直肠癌相关通路进行表征。
Gastroenterol Hepatol Bed Bench. 2021 Spring;14(2):123-131.
9
Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.免疫系统、微生物群和微生物代谢物:结直肠癌微环境中的未解三元体。
Front Immunol. 2021 Mar 26;12:612826. doi: 10.3389/fimmu.2021.612826. eCollection 2021.
10
The Intestinal Microbiota and Colorectal Cancer.肠道微生物群与结直肠癌。
Front Immunol. 2020 Nov 30;11:615056. doi: 10.3389/fimmu.2020.615056. eCollection 2020.